KK
EW icon

KLP Kapitalforvaltning’s Edwards Lifesciences EW Stock Holding History

KLP Kapitalforvaltning’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.3M Buy
303,222
+7,900
+3% +$651K 0.1% 203
2025
Q4 		$25.2M Sell
295,322
-10,900
-4% -$895K 0.1% 190
2025
Q3 		$23.8M Buy
306,222
+14,600
+5% +$1.14M 0.09% 206
2025
Q2 		$22.8M Buy
291,622
+77,400
+36% +$5.77M 0.1% 201
2025
Q1 		$15.5M Sell
214,222
-7,800
-4% -$558K 0.08% 264
2024
Q4 		$16.4M Buy
+222,022
New +$15.5M 0.08% 251

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

KLP Kapitalforvaltning's EW Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Edwards Lifesciences (EW) stake by 2.7% in Q1 2026, buying an estimated $651K and bringing the position to 303,222 shares worth $24.3M. The position accounts for 0.1% of the portfolio, ranked #203.

KLP Kapitalforvaltning first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $25.2M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • KLP Kapitalforvaltning held 303,222 shares of Edwards Lifesciences worth $24.3M as of Q1 2026.
  • KLP Kapitalforvaltning bought 7,900 Edwards Lifesciences shares in Q1 2026, an estimated $651K.
  • Edwards Lifesciences made up 0.1% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #203 holding.
  • KLP Kapitalforvaltning first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Edwards Lifesciences position peaked at $25.2M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.